The findings from our literature study further support a causal connection between pathogenic homozygous and heterozygous rare variants in APOE, with a significant negative impact on APOE function and the presenting phenotype (dysbetalipoproteinemia and splenomegaly) (Table 1). This evidence concerns the gene APOE and hyperlipoproteinemia type 3.